Wedmont Private Capital Bio Techne Corp Transaction History

Wedmont Private Capital

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	BUY	$73.76 - $85.98 $175,622 - $204,718	2,381 New	2,381 $194,000
Q4 2022 Jan 09, 2023	BUY	$80.67 - $352.29 $218,373 - $953,649	2,707 New	2,707 $0
Q2 2022 Jul 11, 2022	SELL	$322.67 - $449.65 $189,729 - $264,394	-588 Closed	0 $0
Q1 2022 Apr 05, 2022	BUY	$353.85 - $487.79 $208,063 - $286,820	588 New	588 $254,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Wedmont Private Capital, based on Form 13F filings with the SEC.

Stay updated on Wedmont Private Capital with notifications on news.